Brief: Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation For Elx-02 For The Treatment Of Cystic Fibrosis

Eloxx Pharmaceuticals

04/08/2020 12:38

Aug 4 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS RECEIVES U.S. ORPHAN DRUG
DESIGNATION FOR
ELX-02 FOR THE TREATMENT OF CYSTIC FIBROSIS

Source text for Eikon:  ID:nGNXpjjxC 
Further company coverage:  ELOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))